Collegium Pharmaceutical (COLL) Non-Current Deferred Tax Liability (2018 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Non-Current Deferred Tax Liability of $11.5 million for Q4 2018.
Collegium Pharmaceutical (COLL) Non-Current Deferred Tax Liability (2018 - 2026) Analysis & Trends
Collegium Pharmaceutical's Non-Current Deferred Tax Liability history runs 1 years deep, the most recent figure standing at $11.5 million for Q4 2018.
- In Q4 2018, Non-Current Deferred Tax Liability changed N/A year-over-year to $11.5 million; the TTM figure through Dec 2018 stood at $11.5 million (changed N/A YoY), while the FY2018 annual figure was $11.5 million, changed N/A from the prior year.
- Non-Current Deferred Tax Liability for Q4 2018 stood at $11.5 million.
- The five-year high for Non-Current Deferred Tax Liability was $11.5 million in Q4 2018, with the low at $11.5 million in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Collegium Pharmaceutical | 892.67 Mn | 743.35 Mn | 110.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 40.97 Mn |
| Jun 30, 2026 | 40.97 Mn |
| Dec 31, 2018 | 11.52 Mn |
| Dec 31, 2018 | 11.52 Mn |